Join
Live feed
·
PRReleasevia Quantisnow
MetaVia Inc. logo

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session

ByQuantisnow·Wall Street's wire, on your screen.
MTVA· MetaVia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTVA (MetaVia Inc.) and more on Quantisnow.